A

Aegirbio AB
F:52Q

Watchlist Manager
Aegirbio AB
F:52Q
Watchlist
Price: 0.1586 EUR -2.1% Market Closed
Market Cap: 5.7m EUR

Operating Margin
Aegirbio AB

-138 105.6%
Current
-69 947%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-138 105.6%
=
Operating Profit
-49.7m
/
Revenue
36k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
SE
Aegirbio AB
STO:AEGIR
6.9m SEK
-138 106%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
395.1B USD
33%
US
Amgen Inc
NASDAQ:AMGN
174.1B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
148.5B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD
28%
AU
CSL Ltd
ASX:CSL
85.8B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD
8%
NL
argenx SE
XBRU:ARGX
44.3B EUR
22%
No Stocks Found

Aegirbio AB
Glance View

Market Cap
5.7m EUR
Industry
Biotechnology

AegirBio AB engages in the development and commercialization of drug monitoring tests. The company is headquartered in Lund, Skane. The company went IPO on 2020-06-26. The firm offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company aims to provide personalized treatment by tracking drugs levels in individuals. Aegirbio combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.

52Q Intrinsic Value
Not Available
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-138 105.6%
=
Operating Profit
-49.7m
/
Revenue
36k
What is the Operating Margin of Aegirbio AB?

Based on Aegirbio AB's most recent financial statements, the company has Operating Margin of -138 105.6%.

Back to Top